玛雅吧

Services

International Market

Hansoh actively implements the internationalization strategy and has been committed itself to human being’s health with its professional expertise, through sales of internationally certified APIs and finished-dose pharmaceutical products to  the U.S. and other countries, and  international multi-center clinical trials for innovative drugs.   


Market Internationalization 

Multiple finished-dose pharmaceutical products and APIs are sold to the global market. 


R&D Internationalization 

Global multi-center clinical trials are under way simultaneously in the U.S. and China for HS-10296, a Category 1.1 innovative oncology drug, amid efforts for global expansion of innovative drugs.